Bronte Capital Management Pty
Bondi Junction, C3files as Bronte Capital Management Pty Ltd.
$888m in 56 US stocks at the end of 30 June 2026. The top 10 are 74.4% of the money. It changed about 9.6% of the portfolio this quarter.
Value
$888m
Stocks
56
Top 10 share
74.4%
Turnover
9.6%
What changed this quarter
New
Bought for the first time this quarter.
- Brown FormanBF-B1.4% of the fund
- Revolution MedicinesRVMD0.4% of the fund
- Ishares TRIJR0.4% of the fund
- Tyler TechnologiesTYL0.3% of the fund
- Treace Medical ConceptsTMCI<0.1% of the fund
- AN2 TherapeuticsANTX<0.1% of the fund
- ALX Oncology HoldingsALXO<0.1% of the fund
- Blend LabsBLND<0.1% of the fund
- PepGenPEPG<0.1% of the fund
- Commerce.comCMRC<0.1% of the fund
- Pacific Biosciences of CaliforniaPACB<0.1% of the fund
- Acumen PharmaceuticalsABOS<0.1% of the fund
- SeerSEER<0.1% of the fund
- Novabridge BiosciencesNBP<0.1% of the fund
- Gossamer BioGOSS<0.1% of the fund
Added
Bought more of a stock they already held.
- Walt DisneyDIS3.9% of the fund+94%
- BBB FoodsTBBB2.5% of the fund+9%
- Global-E OnlineGLBE0.9% of the fund+7%
- RiskifiedRSKD0.3% of the fund+20%
- EnovixENVX<0.1% of the fund+262%
- C4 TherapeuticsCCCC<0.1% of the fund+3%
- Milestone PharmaceuticalsMIST<0.1% of the fund+38%
Cut
Sold some of their stake.
- AlphabetGOOGL12.3% of the fund-20%
- Regeneron PharmaceuticalsREGN11.4% of the fund-6%
- Interactive Brokers GroupIBKR8.7% of the fund-31%
- Visa Inc-Class A Shares8.5% of the fund-8%
- Berkshire HathawayBRK-B8.2% of the fund-6%
- Amazon.comAMZN7.0% of the fund-9%
- Philip Morris InternationalPM6.1% of the fund-12%
- CortevaCTVA4.4% of the fund-9%
- Capital One FinancialCOF3.9% of the fund-7%
- First Citizens BancsharesFCNCA3.3% of the fund-14%
- Aurora InnovationAUR1.7% of the fund-6%
- Vaneck ETF Trust1.6% of the fund-8%
- Sotera HealthSHC1.6% of the fund-6%
- Graham HoldingsGHC1.5% of the fund-10%
- Ishares TRIBB1.4% of the fund-5%
- Alnylam PharmaceuticalsALNY1.2% of the fund-5%
- Chemical & Mining CO of ChileSQM1.0% of the fund-5%
- NewmontNEM0.7% of the fund-8%
- Barrick MiningB0.6% of the fund-8%
- LiveRamp HoldingsRAMP0.5% of the fund-43%
- HerbalifeHLF0.5% of the fund-66%
- Turning Point BrandsTPB0.4% of the fund-5%
- Bath & Body WorksBBWI0.4% of the fund-8%
- Mondelez InternationalMDLZ0.3% of the fund-5%
- Brown FormanBF-A0.3% of the fund-5%
Sold out
Sold their entire stake.
- Brown Forman-100%
- Ishares TRIWO-100%
- PinterestPINS-100%
- Sally Beauty HoldingsSBH-100%
- James River Group HoldingsJRVR-100%
- Caribou BiosciencesCRBU-100%
- Pliant TherapeuticsPLRX-100%
- InvivydIVVD-100%
- Rani Therapeutics HoldingsRANI-100%
- Fractyl HealthGUTS-100%
Holdings
- Visa Inc-Class A Shares
- Share
- 8.5%
- Value
- $75m
- Shares
- 219,914
-8%
- Vaneck ETF Trust
- Share
- 1.6%
- Value
- $14m
- Shares
- 191,580
-8%
- Ishares TRIBB
- Share
- 1.4%
- Value
- $13m
- Shares
- 65,807
-5%
- Barrick MiningB
- Share
- 0.6%
- Value
- $5m
- Shares
- 146,359
-8%
- Ishares TRIJR
- Share
- 0.4%
- Value
- $3m
- Shares
- 23,004
New
- Vaneck ETF Trust
- Share
- 0.3%
- Value
- $2m
- Shares
- 24,568
-8%
- NiceNICE
- Share
- 0.2%
- Value
- $1m
- Shares
- 16,396
-4%
- Novabridge BiosciencesNBP
- Share
- <0.1%
- Value
- $21,824
- Shares
- 11,192
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| AlphabetGOOGL | 12.3% | $109m | 305,165 | -20% |
| Regeneron PharmaceuticalsREGN | 11.4% | $101m | 162,618 | -6% |
| Interactive Brokers GroupIBKR | 8.7% | $77m | 883,526 | -31% |
| Visa Inc-Class A Shares | 8.5% | $75m | 219,914 | -8% |
| Berkshire HathawayBRK-B | 8.2% | $73m | 145,847 | -6% |
| Amazon.comAMZN | 7.0% | $62m | 261,433 | -9% |
| Philip Morris InternationalPM | 6.1% | $54m | 300,176 | -12% |
| CortevaCTVA | 4.4% | $39m | 456,656 | -9% |
| Capital One FinancialCOF | 3.9% | $35m | 173,523 | -7% |
| Walt DisneyDIS | 3.9% | $35m | 360,243 | +94% |
| First Citizens BancsharesFCNCA | 3.3% | $30m | 14,179 | -14% |
| BBB FoodsTBBB | 2.5% | $22m | 533,151 | +9% |
| Aurora InnovationAUR | 1.7% | $15m | 2,186,821 | -6% |
| Vaneck ETF Trust | 1.6% | $14m | 191,580 | -8% |
| Sotera HealthSHC | 1.6% | $14m | 797,138 | -6% |
| Nektar TherapeuticsNKTR | 1.6% | $14m | 198,434 | Held |
| Graham HoldingsGHC | 1.5% | $13m | 11,454 | -10% |
| Ishares TRIBB | 1.4% | $13m | 65,807 | -5% |
| Brown FormanBF-B | 1.4% | $12m | 464,313 | New |
| Alnylam PharmaceuticalsALNY | 1.2% | $11m | 35,384 | -5% |
| Chemical & Mining CO of ChileSQM | 1.0% | $9m | 116,308 | -5% |
| Global-E OnlineGLBE | 0.9% | $8m | 227,644 | +7% |
| NewmontNEM | 0.7% | $6m | 69,494 | -8% |
| Barrick MiningB | 0.6% | $5m | 146,359 | -8% |
| LiveRamp HoldingsRAMP | 0.5% | $5m | 128,348 | -43% |
| HerbalifeHLF | 0.5% | $4m | 323,386 | -66% |
| Revolution MedicinesRVMD | 0.4% | $4m | 18,780 | New |
| Turning Point BrandsTPB | 0.4% | $3m | 40,721 | -5% |
| Ishares TRIJR | 0.4% | $3m | 23,004 | New |
| Bath & Body WorksBBWI | 0.4% | $3m | 143,800 | -8% |
| Mondelez InternationalMDLZ | 0.3% | $3m | 53,234 | -5% |
| RiskifiedRSKD | 0.3% | $3m | 588,251 | +20% |
| Brown FormanBF-A | 0.3% | $3m | 95,365 | -5% |
| Tyler TechnologiesTYL | 0.3% | $2m | 8,302 | New |
| Vaneck ETF Trust | 0.3% | $2m | 24,568 | -8% |
| Paylocity HoldingPCTY | 0.2% | $2m | 17,874 | -51% |
| NiceNICE | 0.2% | $1m | 16,396 | -4% |
| Universal DisplayOLED | 0.1% | $889,193 | 10,269 | -8% |
| Verisk AnalyticsVRSK | <0.1% | $481,499 | 2,682 | -8% |
| EnovixENVX | <0.1% | $92,900 | 41,765 | +262% |
| Treace Medical ConceptsTMCI | <0.1% | $61,996 | 15,577 | New |
| Fate TherapeuticsFATE | <0.1% | $58,698 | 21,740 | -5% |
| AN2 TherapeuticsANTX | <0.1% | $52,732 | 10,895 | New |
| C4 TherapeuticsCCCC | <0.1% | $48,330 | 10,349 | +3% |
| ALX Oncology HoldingsALXO | <0.1% | $37,457 | 18,095 | New |
| Blend LabsBLND | <0.1% | $32,912 | 19,247 | New |
| PepGenPEPG | <0.1% | $31,997 | 17,776 | New |
| Commerce.comCMRC | <0.1% | $30,423 | 10,278 | New |
| Pacific Biosciences of CaliforniaPACB | <0.1% | $30,040 | 17,881 | New |
| Acumen PharmaceuticalsABOS | <0.1% | $28,612 | 10,716 | New |
| SeerSEER | <0.1% | $25,081 | 15,109 | New |
| AlectorALEC | <0.1% | $23,634 | 11,758 | -39% |
| Novabridge BiosciencesNBP | <0.1% | $21,824 | 11,192 | New |
| Coherus OncologyCHRS | <0.1% | $21,367 | 15,262 | -21% |
| Milestone PharmaceuticalsMIST | <0.1% | $19,283 | 14,390 | +38% |
| Gossamer BioGOSS | <0.1% | $11,152 | 67,754 | New |
Options (1)
- Regeneron PharmaceuticalsREGN
- Type
- Call
- Value
- $43m
- Contracts
- 68,600
| Company | Type | Value | Contracts |
|---|---|---|---|
| Regeneron PharmaceuticalsREGN | Call | $43m | 68,600 |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is down 30.2% since 30 June 2025.
Where the money is
Financial services24.1%
Health care16.7%
Media & telecom16.2%
Everyday goods11.0%
Retail & consumer8.9%
Materials6.7%
Technology3.8%
Industrials0.3%
Other12.4%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.